These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24325745)

  • 21. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators.
    Crauste-Manciet S; Sessink PJ; Ferrari S; Jomier JY; Brossard D
    Ann Occup Hyg; 2005 Oct; 49(7):619-28. PubMed ID: 16126757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of surface contamination in a hospital hematology--oncology pharmacy.
    Touzin K; Bussières JF; Langlois E; Lefebvre M
    J Oncol Pharm Pract; 2009 Mar; 15(1):53-61. PubMed ID: 18772214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system.
    Hon CY; Teschke K; Demers PA; Venners S
    Ann Occup Hyg; 2014 Jul; 58(6):761-70. PubMed ID: 24644303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous determination of gemcitabine, taxol, cyclophosphamide and ifosfamide in wipe samples by high-performance liquid chromatography/tandem mass spectrometry: protocol of validation and uncertainty of measurement.
    Sottani C; Turci R; Schierl R; Gaggeri R; Barbieri A; Violante FS; Minoia C
    Rapid Commun Mass Spectrom; 2007; 21(7):1289-96. PubMed ID: 17340557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of platinum surface contamination in veterinary and human oncology centres using inductively coupled plasma mass spectrometry.
    Janssens T; Brouwers EE; de Vos JP; de Vries N; Schellens JH; Beijnen JH
    Vet Comp Oncol; 2015 Sep; 13(3):305-13. PubMed ID: 24034226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 66 Canadian hospitals: A 2016 follow-up study.
    Roland C; Caron N; Bussières JF
    J Occup Environ Hyg; 2017 Aug; 14(8):661-669. PubMed ID: 28574754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques.
    Harrison BR; Peters BG; Bing MR
    Am J Health Syst Pharm; 2006 Sep; 63(18):1736-44. PubMed ID: 16960258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization of the solid sorbent media in monitoring of airborne cyclophosphamide concentrations and the implications for occupational hygiene.
    Odraska P; Dolezalova L; Piler P; Oravec M; Blaha L
    J Environ Monit; 2011 May; 13(5):1480-7. PubMed ID: 21468422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new, validated wipe-sampling procedure coupled to LC-MS analysis for the simultaneous determination of 5-fluorouracil, doxorubicin and cyclophosphamide in surface contamination.
    Bobin-Dubigeon C; Amiand M; Percheron C; Audeval C; Rochard S; Leynia P; Bard JM
    J Anal Toxicol; 2013 Sep; 37(7):433-9. PubMed ID: 23828102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital.
    Hedmer M; Tinnerberg H; Axmon A; Jönsson BA
    Int Arch Occup Environ Health; 2008 Jul; 81(7):899-911. PubMed ID: 18066576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 124 centers.
    Pinet E; Cirtiu CM; Caron N; Bussières JF; Tanguay C
    J Oncol Pharm Pract; 2024 Jan; 30(1):19-29. PubMed ID: 37021440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring Surface Contamination by Antineoplastic Drugs in Italian Hospitals: Performance-Based Hygienic Guidance Values (HGVs) Project.
    Sottani C; Grignani E; Oddone E; Dezza B; Negri S; Villani S; Cottica D
    Ann Work Expo Health; 2017 Oct; 61(8):994-1002. PubMed ID: 29028251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies - the MEWIP project.
    Kiffmeyer TK; Tuerk J; Hahn M; Stuetzer H; Hadtstein C; Heinemann A; Eickmann U
    Ann Occup Hyg; 2013 May; 57(4):444-55. PubMed ID: 23125441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N
    J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of exposure of dispensary drug preparers to cyclophosphamide by passive sampling and liquid chromatography with tandem mass spectrometry.
    Wakui N; Ookubo T; Iwasaki Y; Ito R; Mitui M; Yano Y; Saito K; Nakazawa H
    J Oncol Pharm Pract; 2013 Mar; 19(1):31-7. PubMed ID: 22753612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device.
    Sessink PJ; Connor TH; Jorgenson JA; Tyler TG
    J Oncol Pharm Pract; 2011 Mar; 17(1):39-48. PubMed ID: 20156932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occupational exposure to antineoplastic drugs in hospital environments: potential risk associated with contact with cyclophosphamide- and ifosfamide-contaminated surfaces.
    Mucci N; Dugheri S; Farioli A; Garzaro G; Rapisarda V; Campagna M; Bonari A; Arcangeli G
    Med Pr; 2020 Sep; 71(5):519-529. PubMed ID: 32667290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exposure of hospital pharmacists and nurses to antineoplastic agents.
    McDevitt JJ; Lees PS; McDiarmid MA
    J Occup Med; 1993 Jan; 35(1):57-60. PubMed ID: 8423505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The application of novel field measurement and field evaluation protocols for assessing health care workers' exposure risk to antineoplastic drugs.
    Astrakianakis G; Jeronimo M; Griffiths A; Colombo M; Kramer D; Demers PA; Hon CY
    J Occup Environ Hyg; 2020 Sep; 17(9):373-382. PubMed ID: 32615872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the decontamination of surfaces exposed to cytotoxic drugs in chemotherapy workstations.
    Roberts S; Khammo N; McDonnell G; Sewell GJ
    J Oncol Pharm Pract; 2006 Jun; 12(2):95-104. PubMed ID: 16984748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.